Cargando…
Survival and Histopathological Study of Animals Bearing Ehrlich Tumor Treated With a Rhodium(II) Amidate
The survival of 90% of a tumor-bearing population treated with the complex Rh(2) (CF(3)CONH)(4) was examined and the pharmacological parameter Surv(90) determined. Histopathological alterations raised for this drug in several tissues were studied in Balb-c mice. A Surv(90) dose of 3.8x 10(-5) mol/kg...
Autores principales: | Espósito, Breno Pannia, Zyngier, Szulim Ber, Najjar, Renato, Paes, Roberto Pinto, Ueda, Suely M. Ykko, Barros, José Carlos A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365154/ https://www.ncbi.nlm.nih.gov/pubmed/18475875 http://dx.doi.org/10.1155/MBD.1999.17 |
Ejemplares similares
-
Rh(2)(CF(3)CONH)(4): The First Biological Assays of a Rhodium (II) Amidate
por: Espósito, Breno Pannia, et al.
Publicado: (1997) -
Distribution of Rhodium in Mice Submitted to Treatment With the Adduct of Rhodium Propionate and Sodium Isonicotinate
por: de Souza, Aparecido Ribeiro, et al.
Publicado: (1997) -
Apoptosis Induced by Metal Complexes and Interaction with
Dexamethasone
por: Kim, Jung Sun, et al.
Publicado: (2002) -
Water Soluble Cyclophosphamide Adducts of Rhodium(II) Keto-Gluconate and Glucuronate. Synthesis, Characterization and In Vitro Cytostatic Assays
por: Gil, Eric de Souza, et al.
Publicado: (1999) -
Rhodium-catalyzed oxidative amidation of allylic alcohols and aldehydes: effective conversion of amines and anilines into amides
por: Wu, Zhao, et al.
Publicado: (2016)